• Profile
Close

Hypertonic mannitol for the prevention of intradialytic hypotension: A randomized controlled trial

American Journal of Kidney Diseases May 02, 2019

Mc Causland FR, et al. - In this double-blind, single-center, randomized, controlled trial including subjects needing initiation of hemodialysis (HD) for acute or chronic kidney disease, researchers assessed how the occurrence of intradialytic hypotension (IDH) was influenced by an intervention to minimize intradialytic alterations in plasma osmolality. During the first 3 HD sessions, they administered mannitol (0.25 g/kg/h) vs a similar volume of 0.9% saline solution. Findings revealed that absolute systolic blood pressure decline did not differ between those who received mannitol and those who received saline solution. However, the mannitol group had fewer overall IDH events as well as a nominally lower risk for dialysis sessions being complicated by IDH.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay